Fusion Antibodies PLC Ordinary Shares (LSE:FAB) - Share price


Stock Report

Fusion Antibodies PLC FAB

Last Price
GBX64.00

Day Change
0.00|0.00%

As of 11/07/2019
10:32:22 BST | GBX
Minimum 15 Minutes Delay.

Last Close64.00p
Day Range63.40 - 65.00
Mkt Cap14.14Mil
52-Wk Range25.00 - 130.00
Yield %-
ISINGB00BDQZGK16
Volume1,688
P/E-14.88
P/S0.04
P/CF1.37

Share Price

Total Returns 17/07/2019

 Chg (%)  
More ...
Fusion Antibodies PLC16.36 
FTSE 100 TR GBP2.56
 
Financials
201620172018
More ...
Income Statement
Turnover1.481.912.69
Operating Profit0.030.13-0.71
Net Profit1.150.12-0.70
Reported EPS5.220.54-4.30
Balance Sheet
Current Assets0.690.935.51
Non Current Assets1.181.231.70
Total Assets1.872.167.21
Current Liabilities0.390.430.57
Total Liabilities---
Total Equity1.461.716.58
Cash Flow
Operating Cash Flow0.33-0.040.08
Net Change in Cash0.31-0.134.21
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
02/07/2019PurchaseDr. Paul Gerard Kerr72.906,9205,044.00
02/07/2019PurchaseMs. Sonya Maria Ferguson69.5030,00020,850.00
02/07/2019PurchaseDr. Alan Mawson59.0010,0005,900.00
29/04/2019PurchaseDr. Paul Gerard Kerr77.001,290993.00

Company Profile

Fusion Antibodies PLC is engaged in the research, development and manufacturing of recombinant proteins and antibodies, particularly in the areas of cancer and infectious diseases.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 28/08/2019

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-10.64
Op Mrgn-0.26
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Timothy William Watts
Non-Executive Director, ChairmanDr. Simon Gordon Douglas
Executive Director, Chief Executive OfficerDr. Paul Gerard Kerr
Executive Director, Chief Financial Officer and Company SecretaryMr. James Alexander Fair
Executive Director, Chief Technical OfficerDr. Richard John Buick
Non-Executive DirectorMs. Sonya Maria Ferguson
Non-Executive DirectorDr. Alan Mawson
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.